Toronto, November 17, 2011 - The Canadian Diabetes Association is pleased to announce that it has entered into an agreement with Elsevier to publish the Canadian Journal of Diabetes (CJD) beginning in January 2012.
CJD is Canada's only diabetes-oriented, peer-reviewed, interdisciplinary journal for diabetes healthcare professionals and scientists. It promotes the sharing and enhancement of knowledge to advance the prevention, cure and management of diabetes and related diseases. The journal publishes original research articles and expert reviews, ranging from basic sciences to clinical applications, education, public and population health, and health policy.
"We are very pleased to be partnering with Elsevier," said Michael Cloutier, President and CEO, Canadian Diabetes Association. "They are an innovative and leading publisher in medical information and, together, we will bring the Canadian Journal of Diabetes to new heights of excellence."
Andrew Miller, Executive Publisher, Global Medical Research, Elsevier stated, "We are very proud to be chosen as publisher for Canadian Journal of Diabetes. We look forward to further developing CJD in partnership with the Canadian Diabetes Association for the diabetes research and clinical-care communities."
Under the agreement with Elsevier, the Association will still own the journal, maintain copyright, and retain full editorial control. Elsevier will manage CJD publication, website features, print and online subscriptions, advertising, and marketing.
The decision to partner with Elsevier was reached by the Association after a long and thorough review process. The advantages of Elsevier's global reach and experience in the ever-changing field of scientific publication will not only benefit the CJD and its authors, but its readers as well.
About the Canadian Diabetes Association
Across the country, the Canadian Diabetes Association is leading the fight against diabetes by helping people with diabetes live healthy lives while we work to find a cure. Our community-based network of supporters help us provide education and services to people living with diabetes, advocate for our cause, break ground towards a cure and translate research into practical applications. Visit http://www.diabetes.ca; http://www.facebook.com/CanadianDiabetesAssociation; on Twitter @DiabetesAssoc; call 800-BANTING (226-8464).
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media contacts
Randi Garcha
Canadian Diabetes Association
Manager, National Media Relations & External Communications
416-408-7071
randi.garcha@diabetes.ca
Andrew Miller
Executive Publisher, Global Medical Research Elsevier
44-1865-843823
andrew.miller@elsevier.com
Journal
Canadian Journal of Diabetes